In summary, our first pan-cancer analysis of TXNIP indicated that there were statistical correlations between TXNIP expression and multiple molecular characteristics across different kinds of tumors, including clinical prognosis, TMB/MSI, MMR genes, DNA methylation, immune cell infiltration, protein ubiquitination and phosphorylation. The gene discussed is MRC1; the disease is cancer.